Unvaccinated adults cost U.S. billions in care, lost productivity
A new study has put a price tag on the cost of vaccination non-compliance among U.S. adults, and it reaches into the billions.
Researchers at the University of North Carolina at Chapel Hill conducted the study using data from the Medical Expenditure Panel Survey and the Nationwide Inpatient Sample database and analyzed the total costs—including both the cost of medical treatment and lost productivity—of unvaccinated adults.
Sachiko Ozawa, PhD, MHS, associate professor in the division of practice advancement and clinical education at the University of North Carolina’s Eshelman School of Pharmacy in Chapel Hill, North Carolina, led the study, which examined the actual cost of medication, inpatient and outpatient care and lost productivity related to the failure of adult patients to receive any of 10 vaccines recommended by the Centers for Disease Control and Prevention (CDC).
The 10 vaccines studied protect against hepatitis A and B, herpes zoster, human papillomavirus, influenza, mumps, rubella, meningococcal disease, pneumococcal disease, tetanus, diptheria, pertussis and chickenpox.